...
首页> 外文期刊>Vascular pharmacology >Tetrahydrocurcumin in combination with deferiprone attenuates hypertension, vascular dysfunction, baroreflex dysfunction, and oxidative stress in iron-overloaded mice
【24h】

Tetrahydrocurcumin in combination with deferiprone attenuates hypertension, vascular dysfunction, baroreflex dysfunction, and oxidative stress in iron-overloaded mice

机译:与脱铁酮结合的四氢胶蛋白衰减高血压,血管功能障碍,钡射流功能障碍和铁过载老鼠中的氧化应激

获取原文
获取原文并翻译 | 示例
           

摘要

Excessive iron can generate reactive oxygen species (ROS), leading to oxidative stress that is closely associated with cardiovascular dysfunction. Iron overload was induced in male ICR mice by injection of iron sucrose (10 mg/kg/day) for eight weeks. Iron overload was evidenced by increased serum iron indices. The mice developed increased blood pressure, impaired vascular function and blunted response of the autonomic nervous system. These effects were accompanied by increased malondialdehyde levels in various tissues, increased nitric oxide metabolites in plasma and urine, and decreased blood glutathione. Tetrahydrocurcumin (MU, 50 mg/kg/day), deferiprone (or L1, 50 mg/kg/day) or both was orally administered throughout the period of iron sucrose injection. The treatments significantly alleviated the deleterious cardiovascular effects of iron overload, and were associated with modulation of nitric oxide levels. An imbalance between endothelial nitric oxide synthase (eNOS) and inducible NOS (iNOS) expression in response to iron overload was normalized by THU, L1 or the combination treatment. Moreover, the treatment decreased the upregulated expression levels of gp91(phox), p47(phox) and HO-1. The combination of THU and L1 exerted a greater effect than THU or L1 monotherapy. These results suggest beneficial effects of THU and L1 on iron-induced oxidative stress, hypertension, and vascular dysfunction. (C) 2016 Elsevier Inc. All rights reserved.
机译:过量的铁可以产生活性氧物质(ROS),导致与心血管功能障碍密切相关的氧化应激。通过注射铁蔗糖(10mg / kg /天)诱发铁过载在雄性ICR小鼠中诱导八周。增加的血清铁索引已经证明了铁过载。小鼠产生了增加的血压,血管功能受损,自主神经系统的钝化反应。这些效果伴随着各种组织中的丙二醛水平增加,血浆和尿液中的一氧化氮代谢物增加,血糖降低。在整个铁蔗糖注射期间,口服渗透循环蛋白(MU,50mg / kg /天),脱铁(或L1,50mg /天/天)或两者。这种治疗显着减轻了铁过载的有害心血管作用,并且与一氧化氮水平的调节相关。响应于铁过载的内皮一氧化氮合酶(eNOS)和诱导型NOS(InOS)表达的不平衡由THU,L1或组合处理标准化。此外,治疗降低了GP91(PHOX),P47(PHOX)和HO-1的上调表达水平。 THU和L1的组合施加比THU或L1单疗法更大的效果。这些结果表明THU和L1对铁诱导氧化应激,高血压和血管功能障碍的有益效果。 (c)2016年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号